Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Anthropic’s life science plans; Novartis CEO on China deals; and more
1+ day, 13+ hour ago (134+ words) Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt out of these cookies by checking "Do Not Sell or Store My Personal…...
Amgen shares new analysis with FDA in bid to keep Tavneos on the market
2+ day, 5+ hour ago (67+ words) Endpoints News Amgen shares new analysis with FDA in bid to keep Tavneos on the market Amgen shared a new analysis with the FDA that the company said supports keeping its…...
Biogen’s Alzheimer’s data spur excitement, confusion about tau-targeting drugs
2+ day, 8+ hour ago (66+ words) Endpoints News Biogen’s Alzheimer’s data spur excitement, confusion about tau-targeting drugs LONDON — One of the most anticipated Alzheimer’s studies in the past few years has cre…...
CHMP recommends Minoryx’s ALD drug, rejects Zevra’s Meplyffa
2+ day, 9+ hour ago (63+ words) Endpoints News CHMP recommends Minoryx’s ALD drug, rejects Zevra’s Meplyffa Minoryx Therapeutics finally scored backing from EU regulators for its neurolog…...
Michael Ehlers joins Formation Bio to lead R&D; Black Diamond co-founder dies at 67
2+ day, 12+ hour ago (68+ words) Endpoints News Michael Ehlers joins Formation Bio to lead R&D; Black Diamond co-founder dies at 67 Michael Ehlers left his CEO role at Ascidian Therapeutics, the exon editing…...
Sanofi nixes Kymab-originated OX40L antibody in eczema
2+ day, 12+ hour ago (56+ words) Endpoints News Sanofi nixes Kymab-originated OX40L antibody in eczema Sanofi has decided to stop working on a drug for eczema it had hoped would be a successor to its im…...
FDA to end pilot aimed at preventing production issues
3+ day, 4+ hour ago (59+ words) Endpoints News FDA to end pilot aimed at preventing production issues The FDA said it will end a pilot that was intended to help drugmakers proactively ad…...
FDA adcomm votes in favor of lifting restrictions on popular wellness peptide BPC-157
3+ day, 4+ hour ago (69+ words) Endpoints News FDA adcomm votes in favor of lifting restrictions on popular wellness peptide BPC-157 An FDA advisory committee voted Thursday to recom…...
Sartorius reduces revenue by €26M to refund Trump tariffs to customers
3+ day, 7+ hour ago (63+ words) Endpoints News Sartorius reduces revenue by €26M to refund Trump tariffs to customers Sartorius appears to be the first life science company to detail how tariff…...
Merck CEO cautions Congress on imposing limits on Chinese dealmaking
3+ day, 8+ hour ago (62+ words) Endpoints News Merck CEO cautions Congress on imposing limits on Chinese dealmaking Merck CEO Rob Davis said he has warned Congress and the Trump administration…...